Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AJMC_Journal
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AJMC_Journal
-
Prikvačeni tweet
New year, new look! We’re kicking off the 25th year of
@AJMC_Journal with our popular#HealthIT issue, including a talk with@EricTopol to launch the#AJMC25 interview series. https://bit.ly/36YIYJQ pic.twitter.com/TazaQdbBCZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Novel Technology Found to Distinguish Between
#Parkinson Disease, Multiple System Atrophy#msa@MichaelJFoxOrg Learn more: https://bit.ly/2vbjBGA pic.twitter.com/OnP3Ordp6E
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On April 3rd,
@AJMC_Journal will offer a live training session at our Cranbury, New Jersey office that will allow unparalleled access to experts covering the use of healthcare#economic info and development of#valuebased contracting Register below! https://bit.ly/2GYqga8 pic.twitter.com/Eh8ccuJDsU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Watch as Dr. Joshua Ofman, chief of Corporate Strategy and External Affairs at
@GrailBio, Discusses How Improving Survival, Reducing Costs in#Oncology Vital to Value-Based Care Transition https://bit.ly/36YyCJ5 pic.twitter.com/uYL9qFtWYP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What We're Reading:
#Asbestos Testing in#Talc;#Polypharmacy Use;#Coronavirus Emergency Use Authorization https://bit.ly/2OKFNP9 pic.twitter.com/zwC6KEVaBz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AJMC proslijedio/la je Tweet
Reference-based drug pricing increased the use of lower-cost therapies, according to new study.https://bit.ly/376MaCI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Exchanging
#Healthcare Data: A Look at 3 Standards Competing to Provide Interoperability Read from contributor Brenda Hopkins, Chief of Health Information Officer of@eFaxCorporate https://bit.ly/2ulBVNm pic.twitter.com/lWqmwiVBd9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Experts Warn of
#Child#Flu Outbreak in Detention Centers@UMmedschool https://bit.ly/382Gxq8 pic.twitter.com/j5XZlzc5QW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Although more than twice as many options for antiretroviral treatment (ART) were available in 2018 as were offered in 2012, between 2012 and 2018, the average wholesale price for initial
#ART jumped 34% for most people with#HIV Learn more: https://bit.ly/2Op0T55 pic.twitter.com/zwHlu3G616
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Ibrutinib quickly became the de fact standard of care to treat chronic lymphocytic leukemia, but the high price presents a problem for the US healthcare system." Watch as Dr Adam Olszewski Discusses Growing Ibrutinib Use to Treat CLL https://bit.ly/31rwLvy pic.twitter.com/TKbkVlh1WS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AJMC proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
What We're Reading:
@US_FDA Launches#HIV Drug Database; HIV#Vaccine Trial Fails; NJ Enacts#Coronavirus Task Force https://bit.ly/2v75wde pic.twitter.com/VHwF6yUu23
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read as Dr. Simon Murray, chief medical officer for
@MJHLifeSciences, provides his thoughts on the 2020-2025 Federal Health IT Strategic Plan draft issued by@HHSGov https://bit.ly/392ntZk pic.twitter.com/dQmqnz2OB3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Watch as
@Delgadockdny Explains How Patients With Disabilities Experience#kidney Care Differently https://bit.ly/2RTBDpL pic.twitter.com/P1uOBH4CZE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What We're Reading: US Declares
#Coronavirus a Public Health Emergency;@US_FDA Approves Peanut Allergy Drug#Palforzia; California Healthcare Tax Rejected https://bit.ly/2tq9YU5 pic.twitter.com/f5uf8NXfHp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Discovery Could Enable Effective Treatments for
#Rare#Blood Disease Learn more: https://bit.ly/390Fg39 pic.twitter.com/rP4v5yydYl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AJMC proslijedio/la je Tweet
BREAKING NEWS: Celltrion's
#Wuhan plans on hold for now amid#coronavirus outbreakhttps://www.centerforbiosimilars.com/news/celltrions-wuhan-plans-on-hold-amid-coronavirus-outbreak …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PAPER OF THE WEEK: This week's paper from our editors-in-chief,
@Michael_Chernew and@FendrickVBID, presented the idea of tying a prescription drug's cost-sharing to its clinical value to the patient Read it here! https://bit.ly/2uZzErf pic.twitter.com/Y0N9fwof5S
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A
#SuperBowl special from contributor Tara Vail: Achieving super outcomes w/o super costs in#orthopedic surgeryhttps://www.ajmc.com/contributor/tara-vail/2020/01/achieving-superoutcomes-without-supercosts-reducing-orthopedic-surgery-costs-and-improving-care-in-managed-care-environment …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#OCM Participants Are Willing to Take On 2-Sided Risk,@oncologyCOA Finds Learn more: https://bit.ly/2RKzHjk pic.twitter.com/Fza4aQ5LSA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ICYMI:
#OCM Participants Are Willing to Take On 2-Sided Risk,@oncologyCOA Finds https://bit.ly/36NKEF4 pic.twitter.com/vnmhlUqJPY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.